We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ACST market cap is 34.17M. The company's latest EPS is USD -1.2676 and P/E is -2.66.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.51M | -2.69M | -2.28M | -8.85M | -4.96M |
| Net Income | -4.02M | -3.27M | -2.39M | -3.17M | -2.62M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 196k | 0 | 0 | 0 |
| Operating Income | -24.44M | -16.01M | -15.34M | -52.16M | -12.85M |
| Net Income | -25.51M | -19.68M | -9.82M | -42.43M | -12.85M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 73.03M | 78.21M | 76.19M | 73.3M | 69.72M |
| Total Liabilities | 9.02M | 11.47M | 11.51M | 11.56M | 10.35M |
| Total Equity | 64.01M | 66.75M | 64.68M | 61.74M | 59.36M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 22.85M | 62.46M | 128.62M | 79.12M | 73.3M |
| Total Liabilities | 9.86M | 6.8M | 20.35M | 11.17M | 11.56M |
| Total Equity | 12.99M | 55.66M | 108.27M | 67.96M | 61.74M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.24M | -8.35M | -10.25M | -12.33M | -3.6M |
| Investing | N/A | 110k | -6.44M | 104k | -15k |
| Financing | N/A | 7.36M | 7.36M | 7.36M | N/A |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.94M | -14.32M | -17.23M | -15.91M | -12.33M |
| Investing | 8.14M | -9.86M | -3.52M | 13.15M | 104k |
| Financing | 13.18M | 59.49M | N/A | 304k | 7.36M |
| Market Cap | 34.17M |
| Price to Earnings Ratio | -2.66 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.49 |
| Price to Book Ratio | 0.55 |
| Dividend Yield | - |
| Shares Outstanding | 10.14M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 7.34k |
| 52 Week Change | 59.72% |
| 52 Week High | 3.60 |
| 52 Week Low | 1.98 |
| Spread (Intraday) | 0.43 (11.85%) |
| Company Name | Acasti Pharma Inc |
| Address |
103 carnegie center jersey city, new jersey 08540 |
| Website | https://www.acastipharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
